{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T05:34:34Z","timestamp":1774589674106,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Science & Technology Pillar Program","award":["No. 2014BAI09B12"],"award-info":[{"award-number":["No. 2014BAI09B12"]}]},{"name":"Jiangsu Provincial Special Program of Medical Science","award":["No. BL2014086)"],"award-info":[{"award-number":["No. BL2014086)"]}]},{"name":"Science and Technology Public Welfare project of Zhejiang provincial Science and Technology Department","award":["2014C33273"],"award-info":[{"award-number":["2014C33273"]}]},{"name":"The second batch of Special Research Funds for National Base for Clinical Research of Chinese Medicine","award":["2015H03"],"award-info":[{"award-number":["2015H03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12185-018-2446-y","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T10:11:13Z","timestamp":1522145473000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single center"],"prefix":"10.1007","volume":"108","author":[{"given":"Xuemei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruinan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"2446_CR1","unstructured":"Dessypris EN, Lipton JM. Red cell aplasia. In: Wintrobe\u2019s clinical hematology. 11th ed. Philadelphia: Lippincott Williams &Wilkins; 2004. p. 1421\u20131427."},{"key":"2446_CR2","first-page":"1083","volume-title":"Goldman\u2019s cecil medicine","author":"L Goldman","year":"2011","unstructured":"Goldman L, Schafer AI. Aplastic anemia and related bone marrow failure states. In: Bagby GC, editor. Goldman\u2019s cecil medicine. 24th ed. New York: Elsevier; 2011. p. 1083\u201390.","edition":"24"},{"key":"2446_CR3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/j.1365-2141.2000.02429.x","volume":"111","author":"P Fisch","year":"2000","unstructured":"Fisch P, Handgretinger R, Schaefer HE. Pure red cell aplasia. Br J Haematol. 2000;111:1010\u2013122.","journal-title":"Br J Haematol"},{"key":"2446_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2141.2008.07216.x","volume":"142","author":"K Sawada","year":"2008","unstructured":"Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol. 2008;142:505\u201314.","journal-title":"Br J Haematol"},{"key":"2446_CR5","first-page":"285","volume":"28","author":"AM Marmont","year":"1991","unstructured":"Marmont AM. Therapy of pure red cell aplasia. Semin Hematol. 1991;28:285\u201397.","journal-title":"Semin Hematol"},{"key":"2446_CR6","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1182\/blood.V87.7.3000.bloodjournal8773000","volume":"87","author":"MQ Lacy","year":"1996","unstructured":"Lacy MQ, Kurtin PJ, Tefferi A. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood. 1996;87:3000\u20136.","journal-title":"Blood"},{"key":"2446_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1600-0609.1997.tb00978.x","volume":"59","author":"S Mamiya","year":"1997","unstructured":"Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur J Haematol. 1997;59:199\u2013205.","journal-title":"Eur J Haematol"},{"key":"2446_CR8","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1182\/blood.V97.12.3995","volume":"97","author":"M Zecca","year":"2001","unstructured":"Zecca M, Stefano P, Nobili B, Locatelli F. Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood. 2001;97:3995\u20137.","journal-title":"Blood"},{"key":"2446_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood.V99.3.1092","volume":"99","author":"H Ghazal","year":"2002","unstructured":"Ghazal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocyticleukemia. Blood. 2002;99:1092\u20134.","journal-title":"Blood"},{"key":"2446_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1046\/j.1365-2141.2003.04609.x","volume":"123","author":"X Ru","year":"2003","unstructured":"Ru X, Liebman HA. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol. 2003;123:278\u201381.","journal-title":"Br J Haematol"},{"key":"2446_CR11","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","volume":"128","author":"RT Means Jr","year":"2016","unstructured":"Means RT Jr. Pure red cell aplasia. Blood. 2016;128:2504\u20139.","journal-title":"Blood"},{"key":"2446_CR12","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3324\/haematol.11192","volume":"92","author":"K Sawada","year":"2007","unstructured":"Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K, et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica. 2007;92:1021\u20138.","journal-title":"Haematologica"},{"key":"2446_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3324\/haematol.11655","volume":"93","author":"M Hirokawa","year":"2008","unstructured":"Hirokawa M, Sawada K, Nakao S, Fujishima N, Nakao S, Urabe A, et al. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica. 2008;93:27\u201333.","journal-title":"Haematologica"},{"key":"2446_CR14","volume-title":"Pure red cell aplasia","author":"EN Dessypris","year":"1988","unstructured":"Dessypris EN. Pure red cell aplasia. Baltimore: Johns Hopkins University Press; 1988."},{"issue":"11","key":"2446_CR15","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1182\/blood.V87.11.4831.bloodjournal87114831","volume":"87","author":"RJ Charles","year":"1996","unstructured":"Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood. 1996;87(11):4831\u20138.","journal-title":"Blood"},{"key":"2446_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3324\/haematol.12020","volume":"93","author":"E Montane","year":"2008","unstructured":"Montane E, Ibanez L, Vidal X, Ballarin E, Puig R, Garcia N, et al. Epidemiology of aplastic anemia: a prospective multicenter study. Haematologica. 2008;93:518\u201323.","journal-title":"Haematologica"},{"key":"2446_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1600-0609.2009.01213.x","volume":"82","author":"S Kawahara","year":"2009","unstructured":"Kawahara S, Sasaki M, Isobe Y, Ando J, Noguchi M, Koike M, et al. Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T-cell GLPD in Japan. Eur J Haematol. 2009;82:308\u201314.","journal-title":"Eur J Haematol"},{"issue":"4","key":"2446_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00277-009-0895-3","volume":"89","author":"YL Kwong","year":"2010","unstructured":"Kwong YL, Au WY, Leung AY, Tse EW. T-cell large granu1ar lymphocyte leukemia: an Asian perspective. Ann Hematol. 2010;89(4):331\u20139.","journal-title":"Ann Hematol"},{"key":"2446_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.blre.2006.01.003","volume":"20","author":"EJ Burks","year":"2006","unstructured":"Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev. 2006;20:245\u201366.","journal-title":"Blood Rev"},{"issue":"3","key":"2446_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","volume":"11","author":"L Sokol","year":"2006","unstructured":"Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist. 2006;11(3):263\u201373.","journal-title":"Oncologist"},{"key":"2446_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1756-8722-6-82","volume":"6","author":"ZY Qiu","year":"2013","unstructured":"Qiu ZY, Fan L, Wang L, Qiao C, Wu YJ, Zhou JF, et al. STAT3 mutations are frequent in T-cell large granular lymphocytic leukemia with pure red cell aplasia. J Hematol Oncol. 2013;6:82.","journal-title":"J Hematol Oncol"},{"key":"2446_CR22","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2169\/internalmedicine.52.8291","volume":"52","author":"N Kawano","year":"2013","unstructured":"Kawano N, Nagahiro Y, Yoshida S, Yamashita K, Himeji D, Uezono S, et al. Clinical characteristics and outcomes of 11 patients with pure red cell aplasia at a single institution over a 13-year period. Intern Med. 2013;52:2025\u201330.","journal-title":"Intern Med"},{"key":"2446_CR23","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3324\/haematol.12871","volume":"93","author":"N Fujishima","year":"2008","unstructured":"Fujishima N, Sawada K, Hirokawa M, Oshimi K, Sugimoto K, Matsuda A, et al. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group. Haematologica. 2008;93:1555\u20139.","journal-title":"Haematologica"},{"key":"2446_CR24","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjh.13376","volume":"169","author":"M Hirokawa","year":"2015","unstructured":"Hirokawa M, Sawada K, Fujishima N, Teramura M, Bessho M, Dan K, et al. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004\/2006 by the Japan PRCA collaborative study group. Br J Haematol. 2015;169:879\u201386.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-018-2446-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-018-2446-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T10:17:22Z","timestamp":1570961842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-018-2446-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["2446"],"URL":"https:\/\/doi.org\/10.1007\/s12185-018-2446-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"30 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}